Stockscreener 앱 받기
1.56
4.59%
-0.075
시간 외 거래:
1.61
0.05
+3.21%
전일 마감가:
$1.635
열려 있는:
$1.64
하루 거래량:
300.31K
Relative Volume:
0.57
시가총액:
$6.40M
수익:
$502.40K
순이익/손실:
$-7.91M
주가수익비율:
-0.1564
EPS:
-9.972
순현금흐름:
$-4.32M
1주 성능:
+9.86%
1개월 성능:
+9.09%
6개월 성능:
-49.68%
1년 성능:
-70.29%
1일 변동 폭
$1.46
$1.64
1주일 범위
$1.41
$1.71
52주 변동 폭
$1.215
$12.45
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
명칭
60 Degrees Pharmaceuticals Inc
전화
202-327-5422
주소
1025 CONNECTICUT AVENUE NW, WASHINGTON
SXTP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.56 | 6.71M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스
Measuring 60 Degrees Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Volume & Free Community Supported Trade Ideas - newser.com
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Canton Repository
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - The Holland Sentinel
60 Degrees Pharmaceuticals stockholders approve board, equity plan amendment and reverse split - Investing.com
60 Degrees Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Visual trend scoring systems applied to 60 Degrees Pharmaceuticals Inc.2025 Dividend Review & Short-Term High Return Ideas - newser.com
What high frequency data says about 60 Degrees Pharmaceuticals Inc.2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Can 60 Degrees Pharmaceuticals Inc. stock sustain market leadershipStop Loss & Free AI Powered Buy and Sell Recommendations - newser.com
How buybacks impact 60 Degrees Pharmaceuticals Inc. stock valueJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Is Rajeswari Infrastructure Limiteds Business Model Sustainable Long TermResistance Breakout Alerts & Affordable Investment Tips - earlytimes.in
60 Degrees Pharma names first chronic babesiosis trial B-FREE By Investing.com - Investing.com Canada
60 Degrees Pharma names first chronic babesiosis trial B-FREE - Investing.com India
60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study - GlobeNewswire
Is 60 Degrees Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Why retail investors pile into 60 Degrees Pharmaceuticals Inc. stock2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Can machine learning forecast 60 Degrees Pharmaceuticals Inc. Equity Warrant recoveryJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc Equity Warrant a good long term investmentStraddle and Strangle Trades & High Yield Market Growth - earlytimes.in
Risk adjusted return profile for 60 Degrees Pharmaceuticals Inc. analyzed2025 Biggest Moves & Stock Portfolio Risk Control - newser.com
Will 60 Degrees Pharmaceuticals Inc. rebound enough to break evenJuly 2025 Reactions & Technical Pattern Alert System - newser.com
Earnings visualization tools for 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Volume & Growth Focused Stock Reports - newser.com
What Fibonacci levels say about 60 Degrees Pharmaceuticals Inc. Equity Warrant reboundM&A Rumor & Safe Capital Growth Stock Tips - newser.com
What candlestick patterns are forming on 60 Degrees Pharmaceuticals Inc.July 2025 Market Mood & High Yield Equity Trading Tips - newser.com
Is now a turning point for 60 Degrees Pharmaceuticals Inc. Equity WarrantQuarterly Market Summary & Community Consensus Trade Alerts - newser.com
Analyzing recovery setups for 60 Degrees Pharmaceuticals Inc. investorsLayoff News & Safe Entry Point Alerts - newser.com
What MACD and RSI say about 60 Degrees Pharmaceuticals Inc. Equity WarrantMarket Movers & Advanced Swing Trade Entry Plans - newser.com
What drives 60 Degrees Pharmaceuticals Inc stock priceEarnings Surprise Analysis & Stay Invested. Stay Smart. - earlytimes.in
News impact scoring models applied to 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock gaining market sharePortfolio Risk Report & Fast Gaining Stock Reports - newser.com
Published on: 2025-10-05 02:19:10 - newser.com
Newsmax CEO Christopher Ruddy to Deliver Keynote Address at Maxim Group's 2025 Growth Summit - The Desert Sun
Is this a good reentry point in 60 Degrees Pharmaceuticals Inc. Equity WarrantRisk Management & Daily Entry Point Alerts - newser.com
Sector ETF performance correlation with 60 Degrees Pharmaceuticals Inc.Portfolio Value Summary & Weekly Watchlist of Top Performers - newser.com
Tools to assess 60 Degrees Pharmaceuticals Inc. Equity Warrant’s risk profileMarket Performance Recap & Fast Gaining Stock Strategy Reports - newser.com
60 Degrees Pharmaceuticals Inc (SXTP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
60 Degrees Pharmaceuticals Inc 주식 (SXTP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
5.74%
자본화:
|
볼륨(24시간):